Inventor · disambiguated record
Edward Thein Htun Van Der Horst
Also filed as: VAN DER HORST EDWARD THEIN H · VAN DER HORST EDWARD THEIN HTUN
15 granted patents·6 pending applications·108 citations·filing 2009–2024
92Inventor score
Files withPF MEDICAMENT8ONCOMED PHARM INC6GURNEY AUSTIN L3VAN DER HORST EDWARD THEIN HTUN2IGENICA INC1
Top patents by PatentIndex Score
21 records- 0197US8226943B2Antibodies to notch receptorsGURNEY AUSTIN L·Filed 2009·Granted Jul 24, 2012·49 cites·23 claims
- 0295US8425903B2Methods of treatment by administering antibodies to notch receptorsGURNEY AUSTIN L·Filed 2012·Granted Apr 23, 2013·20 cites·23 claims
- 0393US8455623B2Compositions and methods for diagnosing and treating cancerVAN DER HORST EDWARD THEIN HTUN·Filed 2009·Granted Jun 4, 2013·17 cites·20 claims
- 0488US9132189B2Notch1 binding agents and methods of use thereofONCOMED PHARM INC·Filed 2013·Granted Sep 15, 2015·5 cites·24 claims
- 0588US8980260B2Monoclonal antibody that binds human notch2 and notch3ONCOMED PHARM INC·Filed 2013·Granted Mar 17, 2015·5 cites·16 claims
- 0687US10766959B2Anti-C10ORF54 antibodies and uses thereofPF MEDICAMENT·Filed 2015·Granted Sep 8, 2020·3 cites·15 claims
- 0782US8834875B2Notch1 binding agents and methods of use thereofVAN DER HORST EDWARD THEIN HTUN·Filed 2011·Granted Sep 16, 2014·5 cites·11 claims
- 0880US8652843B2DDR1-binding agents and methods of use thereofGURNEY AUSTIN L·Filed 2009·Granted Feb 18, 2014·2 cites·13 claims
- 0976US9505832B2Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3ONCOMED PHARM INC·Filed 2015·Granted Nov 29, 2016·1 cites·18 claims
- 1075US9206256B2DDR1-binding agents and methods of use thereofONCOMED PHARM INC·Filed 2014·Granted Dec 8, 2015·1 cites·22 claims
- 1173US2025052758A1Receptor for vistaPF MEDICAMENT·Filed 2024·Application pending·0 cites
- 1267US11873339B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2020·Granted Jan 16, 2024·0 cites·24 claims
- 1365US2017198031A1Notch binding agents and antagonists and methods of use thereofONCOMED PHARM INC·Filed 2016·Application pending·0 cites
- 1463US10421818B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2018·Granted Sep 24, 2019·0 cites·4 claims
- 1563US10414823B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2018·Granted Sep 17, 2019·0 cites·4 claims
- 1663US10100123B2Anti-C10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2014·Granted Oct 16, 2018·0 cites·10 claims
- 1763US2020040102A1Anti-c10orf54 antibodies and uses thereofPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 1857US2023243836A1Receptor for vistaPF MEDICAMENT·Filed 2019·Application pending·0 cites
- 1951US2015231240A1Anti-c16orf54 antibodies and methods of use thereofIGENICA INC·Filed 2013·Application pending·0 cites
- 2051US2013316450A1Compositions and Methods for Diagnosing and Treating CancerONCOMED PHARM INC·Filed 2013·Application pending·0 cites
- 2150US10556959B2Anti-CD39 antibodies and uses thereofXENCOR INC·Filed 2015·Granted Feb 11, 2020·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →